MGP Ingredients (MGPI) Q4 2025 Earnings Transcript
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 6 days ago
0mins
Should l Buy MGPI?
Source: NASDAQ.COM
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy MGPI?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on MGPI
Wall Street analysts forecast MGPI stock price to rise
4 Analyst Rating
3 Buy
1 Hold
0 Sell
Strong Buy
Current: 19.170
Low
24.00
Averages
34.75
High
45.00
Current: 19.170
Low
24.00
Averages
34.75
High
45.00
About MGPI
MGP Ingredients, Inc. is a producer of branded and distilled spirits, as well as food ingredient solutions. Its offerings include bourbon and rye whiskeys, gins, and vodkas. It operates through three segments: Distilling Solutions, Branded Spirits, and Ingredient Solutions. Its Distilling Solutions Segment processes corn and other grains (including rye, barley, wheat, barley malt, and milo) into food-grade alcohol and distillery co-products, such as distillers feed, which are produced at its distilleries in Lawrenceburg, Indiana, and Bardstown, Kentucky. Branded Spirits segment consists of a portfolio of brands, which it produces through its distilleries and bottling facilities and sells to distributors or to state governments that directly control the sale of alcohol. Its Ingredient Solutions segment consists of specialty wheat starches, specialty wheat proteins, commodity wheat starches, and commodity wheat protein products which are sold to customers pursuant to purchase orders.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Oversold Stocks in Consumer Staples Present Buying Opportunities
- Overview of Oversold Stocks: According to Benzinga Pro, major players in the consumer staples sector, including Nomad Foods Ltd, Vital Farms, Inc., and MGP Ingredients Inc, have relative strength indices (RSI) near or below 30, indicating these stocks are significantly undervalued and may present buying opportunities for investors.
- RSI Indicator Interpretation: The relative strength index (RSI) serves as a momentum indicator that compares a stock's strength on days when prices rise to its strength on days when prices fall, thereby assisting traders in better assessing short-term stock performance and informing their investment decisions.
- Market Opportunity Analysis: In the current market environment, oversold stocks are often viewed as potential investment opportunities, particularly in the consumer staples sector, where investors can capitalize on these undervalued companies to position themselves for future returns.
- Industry Comparison: Benzinga also provides scores for other stocks in the consumer staples sector, allowing investors to gain a more comprehensive understanding of market dynamics and optimize their portfolios to enhance return potential.
See More
MGP Ingredients Q4 2025 Earnings Call Insights
- Sales Decline: MGP Ingredients reported a 23% year-over-year decline in consolidated sales for Q4 2025, dropping to $138 million, primarily due to expected declines across several business lines, indicating a broader industry weakness.
- Adjusted EBITDA Drop: The adjusted EBITDA for Q4 decreased by 51% to $26 million, with a 41% decline for the full year to $116 million, reflecting challenges in cost control and operational efficiency amid a tough market environment.
- Brand Strategy Rationalization: The company plans to rationalize 20% of its tail brands to reduce complexity and optimize SKUs, which is expected to positively impact sales and profitability in 2026, although short-term industry pressures remain.
- Cautious Future Outlook: Management anticipates net sales for 2026 to range between $480 million and $500 million, with adjusted basic EPS projected between $1.50 and $1.80, reflecting a cautious stance on industry prospects, particularly with expected declines in mid- and value-priced brand sales.
See More
MGP Ingredients (MGPI) Q4 2025 Earnings Transcript
See More
MGP Ingredients Declares Quarterly Dividend of $0.12
- Quarterly Dividend Declaration: MGP Ingredients has declared a quarterly dividend of $0.12 per share, consistent with previous distributions, indicating stable cash flow and profitability, which is likely to bolster investor confidence.
- Dividend Yield: The forward yield of 1.86% reflects the company's attractiveness in the current market environment, potentially drawing in more investors seeking stable income.
- Payment Schedule: The dividend will be payable on March 27, with a record date of March 13 and an ex-dividend date also on March 13, ensuring shareholders receive their returns promptly, thereby strengthening shareholder relations.
- Financial Performance Outlook: MGP Ingredients recently beat top-line and bottom-line estimates while introducing FY26 outlook, indicating future growth potential that may increase market interest in its stock.
See More
MGP Ingredients Q4 Earnings Beat Expectations
- Earnings Performance: MGP Ingredients reported a Q4 non-GAAP EPS of $0.63, beating expectations by $0.13, indicating resilience in profitability despite market challenges.
- Significant Revenue Decline: The revenue of $138.3 million represents a 23.5% year-over-year decline, yet it surpassed market expectations by $5.46 million, suggesting the company maintained some market share amid adversity.
- Adjusted EBITDA Drop: Adjusted EBITDA fell 51% to $26.1 million, reflecting cost pressures and market challenges that could impact future investment decisions and operational strategies.
- Cautious 2026 Outlook: The 2026 sales guidance is projected between $480 million and $500 million, below the consensus of $510.87 million, indicating a conservative approach to future growth amidst ongoing uncertainties.
See More
MGP Ingredients Set to Release Q4 Earnings on February 25
- Earnings Announcement: MGP Ingredients is set to announce its Q4 earnings on February 25 before market open, with a consensus EPS estimate of $0.50, reflecting a significant year-over-year decline of 68.2%, indicating pressure on profitability.
- Revenue Decline: The consensus revenue estimate stands at $132.84 million, representing a 26.5% year-over-year decrease, highlighting challenges the company faces amid competitive market conditions and weak demand, which could impact investor confidence.
- Historical Performance: Over the past two years, MGP Ingredients has consistently beaten EPS and revenue estimates 100% of the time, showcasing strong financial management and adaptability, despite the current downward pressures.
- Market Reaction Expectations: While historical performance has been robust, the significant decline in current earnings expectations may lead to diminished investor confidence in the company's future growth, potentially exerting negative pressure on its stock price.
See More
Oversold Stocks in Consumer Staples Present Buying Opportunities
- Overview of Oversold Stocks: According to Benzinga Pro, major players in the consumer staples sector, including Nomad Foods Ltd, Vital Farms, Inc., and MGP Ingredients Inc, have relative strength indices (RSI) near or below 30, indicating these stocks are significantly undervalued and may present buying opportunities for investors.
- RSI Indicator Interpretation: The relative strength index (RSI) serves as a momentum indicator that compares a stock's strength on days when prices rise to its strength on days when prices fall, thereby assisting traders in better assessing short-term stock performance and informing their investment decisions.
- Market Opportunity Analysis: In the current market environment, oversold stocks are often viewed as potential investment opportunities, particularly in the consumer staples sector, where investors can capitalize on these undervalued companies to position themselves for future returns.
- Industry Comparison: Benzinga also provides scores for other stocks in the consumer staples sector, allowing investors to gain a more comprehensive understanding of market dynamics and optimize their portfolios to enhance return potential.
See More
MGP Ingredients Q4 2025 Earnings Call Insights
- Sales Decline: MGP Ingredients reported a 23% year-over-year decline in consolidated sales for Q4 2025, dropping to $138 million, primarily due to expected declines across several business lines, indicating a broader industry weakness.
- Adjusted EBITDA Drop: The adjusted EBITDA for Q4 decreased by 51% to $26 million, with a 41% decline for the full year to $116 million, reflecting challenges in cost control and operational efficiency amid a tough market environment.
- Brand Strategy Rationalization: The company plans to rationalize 20% of its tail brands to reduce complexity and optimize SKUs, which is expected to positively impact sales and profitability in 2026, although short-term industry pressures remain.
- Cautious Future Outlook: Management anticipates net sales for 2026 to range between $480 million and $500 million, with adjusted basic EPS projected between $1.50 and $1.80, reflecting a cautious stance on industry prospects, particularly with expected declines in mid- and value-priced brand sales.
See More
MGP Ingredients (MGPI) Q4 2025 Earnings Transcript
See More
MGP Ingredients Declares Quarterly Dividend of $0.12
- Quarterly Dividend Declaration: MGP Ingredients has declared a quarterly dividend of $0.12 per share, consistent with previous distributions, indicating stable cash flow and profitability, which is likely to bolster investor confidence.
- Dividend Yield: The forward yield of 1.86% reflects the company's attractiveness in the current market environment, potentially drawing in more investors seeking stable income.
- Payment Schedule: The dividend will be payable on March 27, with a record date of March 13 and an ex-dividend date also on March 13, ensuring shareholders receive their returns promptly, thereby strengthening shareholder relations.
- Financial Performance Outlook: MGP Ingredients recently beat top-line and bottom-line estimates while introducing FY26 outlook, indicating future growth potential that may increase market interest in its stock.
See More
MGP Ingredients Q4 Earnings Beat Expectations
- Earnings Performance: MGP Ingredients reported a Q4 non-GAAP EPS of $0.63, beating expectations by $0.13, indicating resilience in profitability despite market challenges.
- Significant Revenue Decline: The revenue of $138.3 million represents a 23.5% year-over-year decline, yet it surpassed market expectations by $5.46 million, suggesting the company maintained some market share amid adversity.
- Adjusted EBITDA Drop: Adjusted EBITDA fell 51% to $26.1 million, reflecting cost pressures and market challenges that could impact future investment decisions and operational strategies.
- Cautious 2026 Outlook: The 2026 sales guidance is projected between $480 million and $500 million, below the consensus of $510.87 million, indicating a conservative approach to future growth amidst ongoing uncertainties.
See More
MGP Ingredients Set to Release Q4 Earnings on February 25
- Earnings Announcement: MGP Ingredients is set to announce its Q4 earnings on February 25 before market open, with a consensus EPS estimate of $0.50, reflecting a significant year-over-year decline of 68.2%, indicating pressure on profitability.
- Revenue Decline: The consensus revenue estimate stands at $132.84 million, representing a 26.5% year-over-year decrease, highlighting challenges the company faces amid competitive market conditions and weak demand, which could impact investor confidence.
- Historical Performance: Over the past two years, MGP Ingredients has consistently beaten EPS and revenue estimates 100% of the time, showcasing strong financial management and adaptability, despite the current downward pressures.
- Market Reaction Expectations: While historical performance has been robust, the significant decline in current earnings expectations may lead to diminished investor confidence in the company's future growth, potentially exerting negative pressure on its stock price.
See More
